Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
21M
-
Shares change
-
-1.18M
-
Total reported value, excl. options
-
$101M
-
Value change
-
-$36.4M
-
Put/Call ratio
-
0.67
-
Number of buys
-
50
-
Number of sells
-
-56
-
Price
-
$4.78
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2014
140 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q2 2014.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21M shares
of 119M outstanding shares and own 17.62% of the company stock.
Largest 10 shareholders include FMR LLC (3.08M shares), LANSDOWNE PARTNERS (UK) LLP (2.32M shares), Falcon Edge Capital LP (1.79M shares), BlackRock Institutional Trust Company, N.A. (1.34M shares), BVF INC/IL (1.32M shares), VANGUARD GROUP INC (1.21M shares), BlackRock Fund Advisors (843K shares), D. E. Shaw & Co., Inc. (837K shares), WELLINGTON MANAGEMENT CO LLP (728K shares), and IRONWOOD INVESTMENT MANAGEMENT LLC (559K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.